Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by Timerunneron Dec 30, 2017 7:32pm
115 Views
Post# 27252721

RE:2017 Paper press

RE:2017 Paper pressGreat White
 In my 25 plus years of trading I have never seen a company issue so many options and warrants in such a short period of time. If it was on any other exchange what chance would they be able to print that much paper?

However the market does not seem to care much about the past mistakes of many companies. For now only  the new story and the dream of 1000%  returns.

I am not short NF and enjoyed the ride from .14 to .345. This market is absolutley high as a kite on evaluating weed stocks with next to zero  income.  In my opinion this stock should fall back but I would not be surprised if it did  double again. Lets face it you got weed plays evaluated in the billions on  overinflated, bloated possible future revenue?

In this nutsy market NF could go to a $1.00 easier than back to a dime depends on the promotion. This is a promoters/brokers dream market and the promoters/brokers  are  in control, not the  little retail buyer.

I am out of NF for the moment but that does not mean I won't buy back in (to a busy story).

Good Luck to all.


PS: When the weed stocks fall out of favor look out below but until that time there is alot of money to be  for the making.




Bullboard Posts